Four Marijuana Stocks Gaining Speed On Monday

CORAL GABLES, FL / ACCESSWIRE / March 11, 2019 / It's quite astounding that the marijuana stock market continues to receive so much attention despite the nascent nature of the cannabis industry. Typically, investors tend to be more wary of newer industries because their associated companies have yet to prove their worth for a duration of time worthy of determining longterm success. Having said that, the cannabis industry has seen a boom in excitement this past year as a result of lawmakers pushing for legislation in support of marijuana legalization. Running in tandem with these milestones, the medical community has also expressed its support of medicinal cannabis as an effective treatment option for patients suffering from a variety of ailments. If these trends continue, the cannabis sector could generate potential opportunities in the coming months. Global Consortium Inc (OTC:GCGX), Aphria Inc (APHA), Emerald Health Therapeutics Inc (EMHTF), and Innovative Industrial Properties Inc (IIPR) are 4 marijuana stocks heating up on Monday.

Global Consortium Inc (OTC:GCGX) is a company that you might not have heard of but could benefit from checking out as we continue in this new year. Global Consortium is putting in the work to become one of the industry leaders in terms of hemp-derived CBD products, and the market has responded favorably to these strategic moves.

Global Consortium Inc (OTC:GCGX) is determined to make key investments in opportunities support its operating goals, recent of which have included building a ''Cannabis Mall.'' According to reports, the project, once completed, will house manufacturing, distribution, delivery, retail, testing, and cultivation all under one 64,000 sq. ft building.

In recent news, Global Consortium Inc (OTC:GCGX) last week announced that the Company has scheduled an investor conference call for 4:30 PM eastern standard time on Friday, March 22, 2019, at which time Matt Dwyer, the Company's chief executive officer, will provide updates on recent developments and discuss goals for the Company in the coming year.

For More Information On Global Consortium Inc, Click Here

Aphria Inc (APHA) announced earlier this month that Health Canada had granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company's completed Part IV and Part V expansions.

Following the announcement, Irwin Simon, Interim CEO of Aphria, said, "we are ready to hit the ground running and look forward to alleviating industry-wide supply constraints with our greatly expanded production capacity and sophisticated, proprietary automation technology that will ensure Aphria remains at the forefront of cannabis cultivation and innovation. In anticipation of Health Canada's approval, we had allocated a portion of our previously approved capacity to mother and vegetative plants that will be used as the initial growing crops in Part IV and Part V."

For More Information On Aphria Inc, Click Here

Emerald Health Therapeutics Inc (EMHTF) made headlines today when the Company announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms Corp, received from Health Canada its seventh amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. The additional approximately 206,000 square feet of growing area in the fourth and final quadrant of the greenhouse brings Pure Sunfarms' total licensed cannabis production area to approximately 1.03 million sq. ft. in 16 grow rooms.

Dr. Avtar Dhillon, President and Executive Chairman of Emerald, commented, ''with Emerald's 50% stake in one of the largest fully operational cannabis production facilities in the world, we expect to realize significant economic value from Pure Sunfarms. We expect our supply agreement with Pure Sunfarms for 40% of its 2019 production, along with our Quebec and hemp operations, to support strong quarter to quarter sales growth this year.''

For More Information On Emerald Health Therapeutics Inc, Click Here

Innovative Industrial Properties Inc (IIPR) announced just before the end of February that the Company will report results for its fourth quarter and year ended December 31, 2018, after the market closes on Wednesday, March 13, 2019.